In the BioHarmony Drug Report Database

"Preview" Icon

Dolutegravir

Tivicay, Tivicay Pd (dolutegravir) is a small molecule pharmaceutical. Dolutegravir was first approved as Tivicay on 2013-08-12. It is used to treat HIV infections in the USA. It has been approved in Europe to treat HIV infections. Tivicay’s patent is valid until 2029-12-08 (FDA).

 

Trade Name

 

Tivicay
 

Common Name

 

dolutegravir
 

ChEMBL ID

 

CHEMBL1229211
 

Indication

 

hiv infections
 

Drug Class

 

Antivirals: integrase inhibitors

Image (chem structure or protein)

Dolutegravir structure rendering